Finance

Lists
2929:TYO
Pharma Foods International Co., Ltd.
Â¥566.00
+1.80%
(+10.00) 1D
Nov 9, 3:30:00 PM GMT+9  ·   JPY
All symbols
SymbolPriceChange% Change
Generating top insights for 2929...
Open
Â¥571
High
Â¥583
Low
Â¥562
Mkt. cap
16.46B
Avg. vol.
209.82K
Volume
130.20K
Dividend
4.42%
Quarterly dividend
Â¥6
Ex-dividend date
Jul 30, 2026
P/E ratio
8.25
52-wk high
Â¥826
52-wk low
Â¥513
EPS
Â¥69
Shares outstanding
29.03M
No. of employees
625
Open
Â¥571
High
Â¥583
Low
Â¥562
Mkt. cap
16.46B
Avg. vol.
209.82K
Volume
130.20K
Dividend
4.42%
Quarterly dividend
Â¥6
Ex-dividend date
Jul 30, 2026
P/E ratio
8.25
52-wk high
Â¥826
52-wk low
Â¥513
EPS
Â¥69
Shares outstanding
29.03M
No. of employees
625
News stories
From web sources and news partners
About Pharma Foods International Co., Ltd.
CEO-
Employees625
FoundedSep 12, 1997
Headquarters-
SectorHealth Care
IndustryBiotechnology
Previous reportsAll values in JPY
Loading Previous Earnings...
Revenue
Net income
All values in JPY
Oct 2025
Jan 2026
Apr 2026
Jul 2026
Revenue
15.71B
16.73B
16.11B
14.67B
Cost of goods sold
3.08B
3.06B
3.21B
3.17B
Cost of revenue
3.08B
3.06B
3.21B
3.17B
Research and development expenses
332.00M
359.00M
425.00M
742.00M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
14.80B
13.15B
11.54B
6.68B
Operating expense
15.14B
13.52B
11.97B
7.44B
Total operating expenses
18.22B
16.58B
15.18B
10.61B
Operating income
-2.51B
149.00M
931.00M
4.06B
Other non operating income
-131.00M
73.00M
31.00M
142.00M
EBT including unusual items
-2.64B
90.00M
893.00M
3.98B
EBT excluding unusual items
-2.65B
212.00M
895.00M
3.98B
Income tax expense
-749.00M
23.00M
130.00M
934.00M
Effective tax rate
28.37%
25.56%
14.56%
23.45%
Other operating expenses
-
-
-
-
Net income
-1.89B
67.00M
763.00M
3.05B
Net profit margin
-12.04%
0.40%
4.74%
20.79%
Earnings per share
-
-
-
-
Interest and investment income
10.00M
17.00M
9.00M
21.00M
Interest expense
-25.00M
-34.00M
-49.00M
-53.00M
Net interest expenses
-15.00M
-17.00M
-40.00M
-32.00M
Depreciation and amortization charges
-
-
-
-
EBITDA
-2.34B
327.00M
1.12B
4.26B
Gain or loss from assets sale
-4.00M
-
-
-117.00M
Upcoming events
AI content may include mistakes. Learn more
Google apps